Cold Spring Harbor Laboratory:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cold Spring Harbor Laboratory - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9277
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cold Spring Harbor Laboratory (CSHL) is a research and education institution that offers molecular biology and genetics services. The institution offers research services such as graduate research, research training, clinical research, quantitative biology research, postdoctoral research, disease research, and scientific research services. It provides educational services including undergraduate research programs, postgraduate programs, Ph.D. programs, education resources programs, DNA learning centres services, and primary and secondary educational services. CSHL conducts research in the fields of cancer, plant biology, neuroscience, bioinformatics, quantitative biology, genomics, and biological sciences. The institution provides diagnosis services for the treatment of cancer, neurological disorders and other diseases. It caters to scientists in universities, hospitals, and biotech and pharmaceutical sectors in the US. CSHL is headquartered in Cold Spring Harbor, New York, the US.

Cold Spring Harbor Laboratory – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cold Spring Harbor Laboratory, Medical Devices Deals, 2012 to YTD 2018 9
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cold Spring Harbor Labs Enters into Co-Development Agreement with GlaxoSmithKline 11
Ohr Pharma Forms Joint Venture With Cold Spring Harbor Lab 12
Cold Spring Harbor Labs Enters Into Research Agreement With Pfizer For New Cancer Therapies 13
Licensing Agreements 14
uniQure Enters into Licensing Agreement with Cold Spring Harbor Laboratory 14
Hairpin Technologies Enters into Licensing Agreement with Cold Spring Harbor Labs 15
Cold Spring Harbor Laboratory – Key Competitors 16
Cold Spring Harbor Laboratory – Key Employees 17
Cold Spring Harbor Laboratory – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Recent Developments 19
Government and Public Interest 19
Jun 25, 2018: Researchers discover new type of lung cancer 19
May 31, 2018: Organoid profiling identifies treatments for pancreatic cancer 20
May 29, 2018: Scientists show how brain circuit generates anxiety 21
Mar 28, 2018: Revolutionary brain-mapping technique provides new blueprint for cortical connections 22
Mar 08, 2018: CRISPR-based system identifies important new drug targets in a deadly leukemia 23
Feb 14, 2018: Science self-corrects: cancer gene does not pass reproducibility test 24
Feb 07, 2018: Autism Genetics Study Calls Attention to Impaired Motor Skills, General Cognitive Impairment 25
Jan 08, 2018: Throwing a molecular wrench into gene control machine leads to ‘melting away’ of leukemia 26
Nov 16, 2017: 12th Double Helix Medal dinner raises $4.5 million for research & education at Cold Spring Harbor Laboratory 27
Oct 05, 2017: First cell-type census of mouse brains: surprises about structure, male-female differences 28
Product News 29
Dec 07, 2017: Cold Spring Harbor Laboratory Release: Next Generation Lyme Disease Tests Found Efficacious and Ready for Clinical Arena 29
Dec 07, 2017: Next generation Lyme disease tests found efficacious and ready for clinical arena 30
Other Significant Developments 31
Jan 11, 2017: CSHL joins NCI-designated cancer centers in endorsing updated HPV vaccination recommendations 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cold Spring Harbor Laboratory, Deals By Therapy Area, 2012 to YTD 2018 8
Cold Spring Harbor Laboratory, Medical Devices Deals, 2012 to YTD 2018 9
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cold Spring Harbor Labs Enters into Co-Development Agreement with GlaxoSmithKline 11
Ohr Pharma Forms Joint Venture With Cold Spring Harbor Lab 12
Cold Spring Harbor Labs Enters Into Research Agreement With Pfizer For New Cancer Therapies 13
uniQure Enters into Licensing Agreement with Cold Spring Harbor Laboratory 14
Hairpin Technologies Enters into Licensing Agreement with Cold Spring Harbor Labs 15
Cold Spring Harbor Laboratory, Key Competitors 16
Cold Spring Harbor Laboratory, Key Employees 17
Cold Spring Harbor Laboratory, Joint Venture 18

List of Figures
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cold Spring Harbor Laboratory, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cold Spring Harbor Laboratory, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Cold Spring Harbor Laboratory:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cellectar Biosciences Inc (CLRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectar Biosciences Inc (Cellectar) develops phospholipid drug conjugates (PDCs) for the treatment and diagnosis of cancer. Its lead product, CLR 131, is a small-molecule radiotherapeutic PDC, being developed for the treatment of relapse or refractory multiple myeloma. Cellectar’s other pr …
  • Bow Energy Pty Ltd:企業の戦略的SWOT分析
    Bow Energy Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Flipkart Internet Private Limited:企業のM&A・事業提携・投資動向
    Flipkart Internet Private Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Flipkart Internet Private Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析
    Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Japan Airlines Co Ltd:企業の戦略・SWOT・財務分析
    Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ittehad Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Ittehad Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Provimi Holding BV:企業の戦略・SWOT・財務分析
    Provimi Holding BV - Strategy, SWOT and Corporate Finance Report Summary Provimi Holding BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務情報
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Interfor Corp:企業の戦略・SWOT・財務情報
    Interfor Corp - Strategy, SWOT and Corporate Finance Report Summary Interfor Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Stena AB:企業の戦略的SWOT分析
    Stena AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Brainsway Ltd (BRIN):企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Schneider Electric SE (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line includes automation and control products, building management and securit …
  • Vaxart Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vaxart Inc (Vaxart) focuses on the development of recombinant vaccines based on its proprietary oral vaccine delivery platform. The company is currently developing tablet vaccines for seasonal and pandemic influenza, norovirus, and Respiratory Syncytial Virus (RSV). Vaxart’s vaccine delivery …
  • Bonterra Energy Corp (BNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonterra Energy Corp (Bonterra) is an oil and gas company. It acquires and develops producing or undeveloped oil and gas properties. It produces crude oil, natural gas and natural gas liquids. The company principally operates in the provinces of Alberta, British Columbia and Saskatchewan in …
  • NCsoft Corp (036570):企業の財務・戦略的SWOT分析
    NCsoft Corp (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Codexis Inc (CDXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Codexis Inc (Codexis) is a protein engineering company, which develops proteins for a wide range of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, industrial enzymes and fine chemicals, and enzymes as biotherapeutics and for use in molecular diagno …
  • Sequana Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sequana Medical AG (Sequana Medical), formerly NovaShunt AG, is a commercial stage medical device company that offers automated implantable pump systems to monitor fluid balance within the body. The company designs, develops and commercializes alfapump, a fully implantable, programmable, tra …
  • Glen Dimplex Group:企業の戦略的SWOT分析
    Glen Dimplex Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Ario Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ario Pharma Ltd (Ario) is a drug development company that develops new therapeutics for the treatment of pain. The company develops small molecule TRPA1 antagonists to treat neuropathic and inflammatory pain. Its TRPA1 activators include pungent or noxious compounds such as allyl isothiocyan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆